+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Onychomycosis Treatment Market - Global Forecast 2026-2032- Product Image
Onychomycosis Treatment Market - Global Forecast 2026-2032- Product Image
New

Onychomycosis Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5460360
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Onychomycosis Treatment Market is undergoing major transformation, driven by evolving clinical needs, emerging technologies, and regulatory shifts. This analysis delivers strategic insight and actionable guidance for senior decision-makers seeking to strengthen market position and drive sustainable growth in the onychomycosis treatment landscape.

Market Snapshot: Onychomycosis Treatment Market Size and Growth

The Onychomycosis Treatment Market grew from USD 2.29 billion in 2025 to USD 2.52 billion in 2026. It is expected to continue growing at a CAGR of 10.77%, reaching USD 4.70 billion by 2032. Rising demand is fueled by an aging population, the prevalence of comorbidities, greater diagnosis rates, and the development of advanced therapeutics and devices. Stakeholders must adapt to a rapidly evolving environment marked by diagnostic complexity and new access challenges.

Scope & Segmentation Analysis

This report provides an integrated orientation covering the clinical, operational, and market dynamics shaping onychomycosis treatment. Key segmentation and analytical perspectives include:

  • Drug Types: Topical therapies, oral therapies, combination regimens, and laser/device-based interventions.
  • Active Ingredients: Includes amorolfine, ciclopirox, efinaconazole, fluconazole, itraconazole, tavaborole, and terbinafine, each with distinct efficacy and safety considerations.
  • Formulations: Cream, gel, nail lacquer, solution, and tablet or capsule delivery forms affect adherence and usability across care settings.
  • Distribution Channels: Hospital pharmacy, retail pharmacy, and online pharmacy channels influencing product access and reimbursement interaction.
  • Treatment Settings: Home care, outpatient clinics, and hospital inpatient workflows shape administration, monitoring, and device deployment.
  • Demographics: Age groups (below 18, 18 to 65, above 65 years) and gender segments impact labeling, adherence, and marketing strategies.
  • Disease Severity: Stratification by mild to moderate, recurrent, and severe cases guides regimen choices and follow-up protocols.
  • Regions: Market dynamics assessed across Americas, Europe, Middle East & Africa, and Asia Pacific with focus on access, adoption, and regulatory context.
  • Technologies: Molecular diagnostics, enhanced topical and lacquer molecules, device-based therapies, and digital adherence tools.

This broad scope allows leaders to interpret commercial and clinical opportunities from multiple vantage points, supporting informed, evidence-based decisions.

Key Takeaways for Senior Decision-Makers

  • New topical agents with improved nail penetration, alongside minimally invasive devices, are reshaping therapy choices, particularly for localized and refractory cases.
  • Precision diagnostics and molecular assays now support tailored treatment, lowering diagnostic error and enabling better resource allocation.
  • Real-world performance data and outcome tracking are increasingly important for payer negotiations, product positioning, and lifecycle management initiatives.
  • Enhanced digital tools promote adherence, delivering measurable benefits for patient outcomes and therapy completion rates while aiding remote monitoring.
  • Market segmentation by age, gender, and severity enables finely tuned product development, labeling, and targeted marketing—critical for differentiating in competitive channels.
  • Regional variations in access, reimbursement, and regulatory harmonization require adaptive strategies for formulation availability and distribution partnerships.

Tariff Impact and Supply Chain Considerations

Proposed import duty changes and trade policy shifts exert direct influence over the manufacturing and distribution of onychomycosis treatments. Increased tariffs on active pharmaceutical ingredients and device components necessitate supplier diversification and may drive the adoption of localized production strategies to contain costs. These dynamics impact pricing strategies, inventory policies, and the range of commercially viable products, while also affecting payer negotiations and clinical access.

Hospital procurement teams and pharmacy channels may modify procurement approaches, inventory management, and risk mitigation efforts to maintain product availability amid cost pressures. Regulatory compliance remains essential as manufacturers adjust production footprints or sourcing networks.

Methodology & Data Sources

This analysis is grounded in a multi-source methodology, including peer-reviewed literature, clinical trial registries, regulatory and patent filings, and technical white papers. Structured interviews with clinical experts, product developers, procurement leaders, and payer representatives validated findings and operational insights. Cross-validation practices and comprehensive documentation support a transparent, reproducible research framework.

Why This Report Matters

  • Enables strategic planning by providing a 360-degree view of therapeutic, operational, and regulatory drivers shaping the Onychomycosis Treatment Market.
  • Guides technology, sourcing, and commercialization decisions with actionable insights for manufacturers, payers, and providers.
  • Supports targeted investments, product differentiation, and supply chain resilience initiatives to sustain long-term competitive advantage.

Conclusion

Sustained market growth and evolving clinical needs demand adaptive, evidence-driven strategies in onychomycosis treatment. Stakeholders who align innovation, operational flexibility, and real-world outcomes will be best positioned to deliver measurable improvements for patients and business objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Onychomycosis Treatment Market, by Drug Type
8.1. Combination Therapy
8.2. Laser Therapy
8.3. Oral Therapy
8.4. Topical Therapy
9. Onychomycosis Treatment Market, by Active Ingredient
9.1. Amorolfine
9.2. Ciclopirox
9.3. Efinaconazole
9.4. Fluconazole
9.5. Itraconazole
9.6. Tavaborole
9.7. Terbinafine
10. Onychomycosis Treatment Market, by Formulation
10.1. Cream
10.2. Gel
10.3. Nail Lacquer
10.4. Solution
10.5. Tablet Capsule
11. Onychomycosis Treatment Market, by Treatment Setting
11.1. Home Care
11.2. Hospital Inpatient
11.3. Outpatient Clinic
12. Onychomycosis Treatment Market, by Age Group
12.1. 18 To 65 Years
12.2. Above 65 Years
12.3. Below 18 Years
13. Onychomycosis Treatment Market, by Gender
13.1. Female
13.2. Male
14. Onychomycosis Treatment Market, by Disease Severity
14.1. Mild To Moderate
14.2. Recurrent
14.3. Severe
15. Onychomycosis Treatment Market, by Distribution Channel
15.1. Hospital Pharmacy
15.2. Online Pharmacy
15.3. Retail Pharmacy
16. Onychomycosis Treatment Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Onychomycosis Treatment Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Onychomycosis Treatment Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. United States Onychomycosis Treatment Market
20. China Onychomycosis Treatment Market
21. Competitive Landscape
21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. Bausch Health Companies Inc.
21.6. Bayer AG
21.7. Dr. Reddy's Laboratories Ltd.
21.8. Galderma S.A.
21.9. Johnson & Johnson Services, Inc.
21.10. LEO Pharma A/S
21.11. Novartis AG
21.12. Pfizer Inc.
21.13. Sanofi S.A.
21.14. Sun Pharmaceutical Industries Ltd.
21.15. Teva Pharmaceutical Industries Ltd.
21.16. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ORAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ORAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ORAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TOPICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TOPICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TOPICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AMOROLFINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AMOROLFINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AMOROLFINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CICLOPIROX, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CICLOPIROX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CICLOPIROX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY EFINACONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY EFINACONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY EFINACONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ITRACONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ITRACONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TAVABOROLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TAVABOROLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TAVABOROLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY NAIL LACQUER, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY NAIL LACQUER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY NAIL LACQUER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TABLET CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TABLET CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TABLET CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL INPATIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY 18 TO 65 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY 18 TO 65 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY 18 TO 65 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ABOVE 65 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ABOVE 65 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ABOVE 65 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY BELOW 18 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY BELOW 18 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY BELOW 18 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MILD TO MODERATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MILD TO MODERATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MILD TO MODERATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RECURRENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RECURRENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RECURRENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SEVERE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SEVERE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SEVERE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 140. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 142. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 143. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 157. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 158. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 159. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 160. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 161. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 162. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 163. AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 177. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 178. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 179. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 180. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 181. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 182. ASEAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 185. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 186. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 187. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 188. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 189. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 190. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 191. GCC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 203. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 204. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 205. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 206. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 207. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 208. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 209. BRICS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 212. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 213. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 214. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 215. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 216. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 217. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 218. G7 ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 221. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 222. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 223. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 224. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 225. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 226. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 227. NATO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 240. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 241. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 242. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 243. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 244. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 245. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 246. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Onychomycosis Treatment market report include:
  • Bausch Health Companies Inc.
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd.
  • Galderma S.A.
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.52 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.7 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Onychomycosis Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Onychomycosis Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Onychomycosis Pipeline Analysis Report 2025 - Product Image

Onychomycosis Pipeline Analysis Report 2025

  • Report
  • 200 Pages
  • Global
From
Onychomycosis Market Report and Forecast 2025-2034 - Product Image

Onychomycosis Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 126 Pages
  • Global
From
Onychomycosis - Pipeline Insight, 2025 - Product Image

Onychomycosis - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Onychomycosis Drug Market

Onychomycosis is a fungal infection of the nail, which is a common condition affecting the toenails and fingernails. It is caused by a variety of fungi, including dermatophytes, yeasts, and molds. Treatment of onychomycosis is typically done with antifungal drugs, which are part of the infectious diseases drugs market. These drugs are used to treat a variety of fungal infections, including onychomycosis. The onychomycosis drug market is composed of a variety of antifungal drugs, including topical and oral medications. Topical medications are applied directly to the affected nail, while oral medications are taken by mouth. These drugs are used to treat the infection and prevent it from spreading. The onychomycosis drug market is highly competitive, with many companies offering a variety of antifungal drugs. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. These companies offer a range of antifungal drugs, including topical and oral medications, to treat onychomycosis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.